← Back to Search

Educational Brochure for Chemotherapy Toxicity (D-CRSE Trial)

N/A

Waitlist Available

Led By Monali Vasekar, MD

Research Sponsored by Milton S. Hershey Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

D-CRSE Trial Summary

This trial aims to develop an educational brochure to help patients better understand and manage side effects from cytotoxic chemotherapy.

Eligible Conditions

Chemotherapy Toxicity
Chemotherapy Side Effects

D-CRSE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Utility of Educational Brochure assessment

Secondary outcome measures

Baseline Educational Assessment

Emotional Assessment

Symptom Assessment

Other outcome measures

Feasibility Assessment

D-CRSE Trial Design

1Treatment groups

Experimental Treatment

Group I: InterventionalExperimental Treatment1 Intervention

Single arm, interventional. All participants will be administered Educational Brochure to educate them regarding management of side effects experienced during chemotherapy treatment

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor

494 Previous Clinical Trials

2,798,806 Total Patients Enrolled

Monali Vasekar, MDPrincipal Investigator - Penn State Cancer Institute

Penn State Geisinger Rehabilitation Center, Penn State Milton S. Hershey Medical Center, The Milton S Hershey Medical Center Physicians Group

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for people to enroll in this clinical trial?

"According to the details found on clinicaltrials.gov, this research is still recruiting participants. It was initially posted in March 2021 and last edited in January 2022."

Answered by AI

How many participants are eligible for this research undertaking?

"Affirmative. The information hosted on clinicaltrials.gov demonstrates that this study, which was originally published on March 24th 2021, is currently accepting applicants. Altogether 50 patients must be enrolled from 1 test site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Diminish Chemotherapy Related Side Effects Through Patient Education

Monali Vasekar 2021. "Diminish Chemotherapy Related Side Effects Through Patient Education". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04694794.